1. E. Bradshaw Bunney, MD Acute Ischemic Stroke Update

2. E. Bradshaw Bunney, MD FERNE Brain Illness and Injury Course

3. E. Bradshaw Bunney, MD 4 th Mediterranean Emergency Medicine Congress Sorrento, Italy September 17, 2007 4 th Mediterranean Emergency Medicine Congress Sorrento, Italy September 17, 2007

4. E. Bradshaw Bunney, MD E. Bradshaw Bunney Associate Professor E. Bradshaw Bunney Associate Professor Department of Emergency Medicine University of Illinois College of Medicine Chicago, IL

5. E. Bradshaw Bunney, MD Attending Physician Emergency Medicine University of Illinois Hospital Our Lady of the Resurrection Hospital Chicago, IL

6. E. Bradshaw Bunney, MD Board Member FERNE Chicago, IL

7. E. Bradshaw Bunney, MD Disclosures Genentech, AstraZeneca advisory groupGenentech, AstraZeneca advisory group ACEP Scientific Review CommitteeACEP Scientific Review Committee Executive Board, FERNEExecutive Board, FERNE FERNE support by Abbott, Eisai, Pfizer, UCBFERNE support by Abbott, Eisai, Pfizer, UCB

8. E. Bradshaw Bunney, MD www.ferne.org

9. Key Clinical Questions What is primary stroke center designation? What is primary stroke center designation? What stroke surveillance systems currently exist? What stroke surveillance systems currently exist? How are patients not at stroke centers treated? How are patients not at stroke centers treated? How are telemedicine systems utilized in these stroke systems? How are telemedicine systems utilized in these stroke systems?

10. E. Bradshaw Bunney, MD Key Clinical Questions What therapies exist in 2007 for the treatment of ischemic stroke after 3 hours? What therapies exist in 2007 for the treatment of ischemic stroke after 3 hours? What new therapies are on the horizon and how will they impact the EM management of stroke? What new therapies are on the horizon and how will they impact the EM management of stroke? What is new in the 2007 ASA Guidelines? What is new in the 2007 ASA Guidelines?

11. E. Bradshaw Bunney, MD Case 19 yo female collapsed a work on Super Bowl Sunday 2006 19 yo female collapsed a work on Super Bowl Sunday 2006 EMS found her not moving her right side, aphasic, eyes deviated to the left EMS found her not moving her right side, aphasic, eyes deviated to the left Onset time 20 minutes prior to EMS arrival Onset time 20 minutes prior to EMS arrival BP 120/62, HR 84, RR 14 BP 120/62, HR 84, RR 14

12. E. Bradshaw Bunney, MD Case In ED – Friend confirms onset time In ED – Friend confirms onset time Friend states no PMHx, no drug or alcohol use Friend states no PMHx, no drug or alcohol use PE - R arm 0/5 strength, R leg 3/5, aphasic, eyes deviated to L PE - R arm 0/5 strength, R leg 3/5, aphasic, eyes deviated to L No family available No family available

13. E. Bradshaw Bunney, MD Case Glucose = 97 Glucose = 97 Not pregnant Not pregnant CBC, electrolytes, coagulation all normal CBC, electrolytes, coagulation all normal CT head = normal CT head = normal Differential Diagnosis: Differential Diagnosis: Stroke Stroke Multiple Sclerosis Multiple Sclerosis Hysteria Hysteria Conversion Reaction Conversion Reaction Intoxicant Intoxicant

14. E. Bradshaw Bunney, MD Stroke in Perspective

15. E. Bradshaw Bunney, MD Patient Aversion to Various Stroke Outcomes Solomon NA et al Stroke 1994 25(9):1721-5. Aversion:

16. E. Bradshaw Bunney, MD Patient care areas Patient care areas Acute stroke teams Acute stroke teams Written care protocols Written care protocols Emergency medical services Emergency medical services Emergency department Emergency department Stroke unit Stroke unit Neurosurgical services Neurosurgical services Support services Support services Stroke center director Stroke center director Neuroimaging services Neuroimaging services Laboratory services Laboratory services Outcome and quality improvement activities Outcome and quality improvement activities Continuing medical education Continuing medical education Alberts MJ, et al. JAMA. 2000;283:3102-3109. Primary Stroke Centers

17. E. Bradshaw Bunney, MD Primary Stroke Centers Approximately 5,000 hospitals in the US Approximately 5,000 hospitals in the US As of June 2007 there are 352 certified Stroke Centers As of June 2007 there are 352 certified Stroke Centers 94 more in the pipeline 94 more in the pipeline 40 states 40 states State certification in several states State certification in several states

18. E. Bradshaw Bunney, MD Stroke Registries Senator Paul Coverdell from Georgia Senator Paul Coverdell from Georgia Died July 2000 Died July 2000 CDC awarding grants to states to establish registries CDC awarding grants to states to establish registries National link National link

19. E. Bradshaw Bunney, MD Coverdell Stroke Registry 6867 stroke admissions at 98 hospitals 6867 stroke admissions at 98 hospitals 4 states (MI, GA, OH, MA) 4 states (MI, GA, OH, MA) Less that 2/3 had documented onset times. Less that 2/3 had documented onset times. Less than 50% had: Less than 50% had: dysphagia screening (45%) dysphagia screening (45%) lipid testing (34%) lipid testing (34%) smoking cessation counseling (21%) smoking cessation counseling (21%) 3% received tPA in MI, GA, OH, while 8% received tPA in MA. 3% received tPA in MI, GA, OH, while 8% received tPA in MA. Conclusion: only a minority of acute stroke patients are treated according to established guidelines. Conclusion: only a minority of acute stroke patients are treated according to established guidelines. Protocols will be redesigned to improve compliance with the established guidelines which may reveal outcomes benefit. Protocols will be redesigned to improve compliance with the established guidelines which may reveal outcomes benefit.

20. E. Bradshaw Bunney, MD Stroke Networks Consultation agreements Consultation agreements Rotating call between institutions Rotating call between institutions Consolidating resources among a network of hospitals Consolidating resources among a network of hospitals Uniform protocol usage Uniform protocol usage Maximize therapy usage Maximize therapy usage

21. E. Bradshaw Bunney, MD Rural Nevada One designated stroke center One designated stroke center 25 rural EDs 25 rural EDs One protocol agreed to by all hospitals One protocol agreed to by all hospitals Central stroke team Central stroke team Site visits to confirm protocol adherence and promote team approach Site visits to confirm protocol adherence and promote team approach Help to raise the treatment of stroke patients to a common norm Help to raise the treatment of stroke patients to a common norm

22. E. Bradshaw Bunney, MD Telemedicine Systems Two-way videoconferencing to connect a treating physician with a remote consultant Two-way videoconferencing to connect a treating physician with a remote consultant Management option for the treatment of acute stroke patients in hospitals without the resources to provide acute stroke care. Management option for the treatment of acute stroke patients in hospitals without the resources to provide acute stroke care.

23. E. Bradshaw Bunney, MD Telemedicine Systems Telemedicine consultation on 24 acute stroke patients Telemedicine consultation on 24 acute stroke patients 6 (25%) received tPA 6 (25%) received tPA door to needle time of 106 (+/- 22) minutes door to needle time of 106 (+/- 22) minutes consult to needle time of 36 (+/- 15) minutes. consult to needle time of 36 (+/- 15) minutes. No protocol violations No protocol violations May increase the number of stroke patients receiving therapy May increase the number of stroke patients receiving therapy May assist in delineating a group of patients that can receive optimal treatment at the originating hospital thus improving the utilization of scarce resources. May assist in delineating a group of patients that can receive optimal treatment at the originating hospital thus improving the utilization of scarce resources.

24. E. Bradshaw Bunney, MD Ischemic Stroke Treatment

25. E. Bradshaw Bunney, MD Treatment : Thrombolysis NINDS 1995, 3 hour window NINDS 1995, 3 hour window 30 day: absolute benefit toward favorable outcome 14% (relative 30%) (OR 1.7) 30 day: absolute benefit toward favorable outcome 14% (relative 30%) (OR 1.7) Symptomatic ICH 6.4% vs 0.6% Symptomatic ICH 6.4% vs 0.6% Mortality the same Mortality the same

26. E. Bradshaw Bunney, MD Treatment : Thrombolysis  14% absolute increase for the best clinical outcomes as measured by an NIHSS of 0-1.  Benefit = Need to treat 8 patients with t-PA in order to have 1 additional patient with this best outcome.  6% absolute increase in the number of symptomatic ICH.  Harm = Will have one symptomatic ICH for every 16 patients treated with t-PA.  2 patients will have a minimal or no deficit for everyone patient with a symptomatic ICH

27. E. Bradshaw Bunney, MD CT Imaging

28. E. Bradshaw Bunney, MD CT Head

29. E. Bradshaw Bunney, MD CT Angio & Perfusion

30. E. Bradshaw Bunney, MD CTA and CTP Essential questions Essential questions Is there hemorrhage? Is there hemorrhage? Is there large vessel occlusion? Is there large vessel occlusion? Is there “irreversibly” infarcted core? Is there “irreversibly” infarcted core? Is there “at risk” penumbra? Is there “at risk” penumbra? One contrast bolus yields two datasets One contrast bolus yields two datasets Vessel patency Vessel patency Infarct versus salvageable penumbra Infarct versus salvageable penumbra

31. E. Bradshaw Bunney, MD MR Imaging

32. E. Bradshaw Bunney, MD DWI/PWI Mismatch Subtract DWI hyperintense signal area from the PWI hypoperfused area = DWI/PWI mismatch Subtract DWI hyperintense signal area from the PWI hypoperfused area = DWI/PWI mismatch Hypoperfused area that is still viable (penumbra) Hypoperfused area that is still viable (penumbra) Target area for reperfusion Target area for reperfusion

33. E. Bradshaw Bunney, MD New Therapies

34. E. Bradshaw Bunney, MD Intra-Arterial Thrombolysis Two randomized trials – PROACT 1 & 2 Two randomized trials – PROACT 1 & 2 Tested prourokinase vs. heparin <6 hours Tested prourokinase vs. heparin <6 hours MCA occlusions only MCA occlusions only Recanalization improved with IA Recanalization improved with IA Mortality identical Mortality identical Relative risk reduction for outcome – 60% Relative risk reduction for outcome – 60% Risk of invasive procedure Risk of invasive procedure

35. E. Bradshaw Bunney, MD IA in Clinical Practice Numerous clinical series published Numerous clinical series published Basilar artery thrombosis series suggest benefit Basilar artery thrombosis series suggest benefit Benefit with basilar may be late (12-24 hrs) Benefit with basilar may be late (12-24 hrs) MRI diffusion/perfusion may aid selection MRI diffusion/perfusion may aid selection

36. E. Bradshaw Bunney, MD Pre- and Post IA t-PA

37. E. Bradshaw Bunney, MD Mechanical Clot Removal Mechanical Clot Removal Invasive neuroradiologist/neurosurgeon Invasive neuroradiologist/neurosurgeon Window extended to 8 to 12 hours Window extended to 8 to 12 hours Intra-arterial thrombolysis may be given after clot removal Intra-arterial thrombolysis may be given after clot removal

38. E. Bradshaw Bunney, MD Multi MERCI Trial N = 164 N = 164 Baseline NIHSS = 19.3 Baseline NIHSS = 19.3 Revascularization = 68% Revascularization = 68% Good Outcome (90-day mRS < 2) = 36% Good Outcome (90-day mRS < 2) = 36% SICH = 9.8% SICH = 9.8% Mortality at 90 days = 33% Mortality at 90 days = 33%

39. E. Bradshaw Bunney, MD Multi MERCI Trial Subgroup of 29% (48/164) that failed IV t-PA Subgroup of 29% (48/164) that failed IV t-PA Revascularization = 73% Revascularization = 73% mRS < 2 at 90 days = 38% mRS < 2 at 90 days = 38% SICH 10.4% SICH 10.4%

40. E. Bradshaw Bunney, MD MERCI Clot Retriever

41. E. Bradshaw Bunney, MD MERCI Clot Retriever

42. E. Bradshaw Bunney, MD Desmoteplase DIAS, DEDAS studies DIAS, DEDAS studies More fibrin specific, longer half life More fibrin specific, longer half life MRI diffusion / perfusion mismatch >20% MRI diffusion / perfusion mismatch >20% NIHSS 4-20 NIHSS 4-20 3-9 hours after onset 3-9 hours after onset

43. E. Bradshaw Bunney, MD Desmoteplase N = 37 N = 37 No symptomatic ICH No symptomatic ICH Reperfusion: Reperfusion: Placebo 37% Placebo 37% 125 ug/kg 53% 125 ug/kg 53% Good clinical outcome (composite): Good clinical outcome (composite): Placebo 25% Placebo 25% 125 ug/kg 60% 125 ug/kg 60%

44. E. Bradshaw Bunney, MD ASA Guidelines 2007 New EMS Section New EMS Section Educate the public Educate the public EMS use of scales EMS use of scales “Closest institution that can provide emergency stroke care” “Closest institution that can provide emergency stroke care” New Stroke Center Section New Stroke Center Section Creation of Primary Stroke Center strongly recommended Creation of Primary Stroke Center strongly recommended Develop Comprehensive Stroke Centers Develop Comprehensive Stroke Centers Bypass hospitals that do not have the resources to treat stroke Bypass hospitals that do not have the resources to treat stroke

45. E. Bradshaw Bunney, MD ASA Guidelines 2007 ED Evaluation Section (Not Changed) ED Evaluation Section (Not Changed) Develop strict protocol Develop strict protocol Use stroke scale Use stroke scale Imaging Section Imaging Section CT provides the information needed to treat CT provides the information needed to treat Dense artery sign assoc. with poor outcome Dense artery sign assoc. with poor outcome CTA and MR provide additional information CTA and MR provide additional information Insufficient data to say that other signs on CT should stop therapy Insufficient data to say that other signs on CT should stop therapy Do not delay treatment for other images Do not delay treatment for other images

46. E. Bradshaw Bunney, MD ASA Guidelines 2007 Management Section Management Section Management of HTN is controversial Management of HTN is controversial No good data to guide selection of BP meds, NTG paste?? No good data to guide selection of BP meds, NTG paste?? If treat must maintain BP at 180/105 for 24 h If treat must maintain BP at 180/105 for 24 h Glucose >140 mg/dl: poor outcome seen Glucose >140 mg/dl: poor outcome seen TPA Section TPA Section Caution should be exercised in treating pts with major deficits, NIHSS > 20 Caution should be exercised in treating pts with major deficits, NIHSS > 20 Aware of side effect of angioedema Aware of side effect of angioedema Seizure is not a contraindication Seizure is not a contraindication

47. E. Bradshaw Bunney, MD Case Outcome Small hospital, no neurologist interested in seeing the patient Small hospital, no neurologist interested in seeing the patient Called 2 Universities before finding one to accept the patient Called 2 Universities before finding one to accept the patient Family arrived, patient not improving Family arrived, patient not improving

48. E. Bradshaw Bunney, MD Case Outcome Stroke neurologist = “Give IV t-PA” Stroke neurologist = “Give IV t-PA” t-PA given at 2 hours 15 minutes from onset t-PA given at 2 hours 15 minutes from onset R arm movement and aphasia improving prior to transfer R arm movement and aphasia improving prior to transfer

49. E. Bradshaw Bunney, MD Case Outcome MRI at University = small infarct MRI at University = small infarct ECHO cardiogram = Patent foramen ovale, likely embolic stroke ECHO cardiogram = Patent foramen ovale, likely embolic stroke Outcome = normal except small vision loss. Outcome = normal except small vision loss.

50. E. Bradshaw Bunney, MD Conclusions Stroke center certification provides a method of measuring quality improvement in stroke patient care Stroke center certification provides a method of measuring quality improvement in stroke patient care Stroke networks allow a region to achieve a particular quality standard Stroke networks allow a region to achieve a particular quality standard Outcomes measurement needs to be continued to establish the role of stroke systems as well as therapies Outcomes measurement needs to be continued to establish the role of stroke systems as well as therapies

51. E. Bradshaw Bunney, MD Conclusions IA thrombolysis and mechanical clot removal provide an alternative at institutions able to use it IA thrombolysis and mechanical clot removal provide an alternative at institutions able to use it CTA and CT perfusion may become routine CTA and CT perfusion may become routine “Time is brain” may be replaced by “Physiology is brain” “Time is brain” may be replaced by “Physiology is brain”

52. E. Bradshaw Bunney, MD Conclusions Accurate measurement of the penumbra may surpass the strict time nature of treatment Accurate measurement of the penumbra may surpass the strict time nature of treatment New therapies based on the percent of penumbra remaining may allow for time to be relatively unimportant New therapies based on the percent of penumbra remaining may allow for time to be relatively unimportant

53. E. Bradshaw Bunney, MD Questions? www.FERNE.org bbunney@uic.edu 312 413 7484 ferne_memc_2007_braincourse_bunney_ais_091707_finalcd 8/2/2015 1:04 AM